As the Group Head of Technology and Innovation at Fresenius Group, Wolfgang Hofmann is responsible for driving the organization's technological advancement and innovative initiatives within the healthcare sector. He focuses on developing markets for future growth through business incubation, corporate venture capital, and transformative mergers and acquisitions. His particular areas of interest include Gene Therapy, Healthcare Ecosystems, and Generative AI in healthcare. In addition, he serves as a member of executive industry advisory boards, contributing his expertise to organizations such as Healthcare Business International and the Generative AI Summit.
Prior to his role as the Group Head of Technology and Innovation, Wolfgang Hofmann served as the Group Head of Corporate Investments at Fresenius Group. In this capacity, he led corporate investment strategies and activities to enhance the organization's growth and portfolio diversification.
Dive into the crucial process of curating a robust generative AI strategy for transformative business outcomes.
- Aligning generative AI strategy with overarching business goals for seamless integration and impactful outcomes.
- Collaborating across departments to gather diverse perspectives, ensuring a holistic and comprehensive generative AI strategy.
- Regularly reassessing and iterate the generative AI strategy to adapt to evolving business landscapes and technologies.
Check out the incredible speaker line-up to see who will be joining Wolfgang.
Download The Latest Agenda